Anthera Pharmaceuticals 

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

Find out more about what we are doing for patients with Cystic Fibrosis, Systemic Lupus Erythematosus, and IgA Nephropathy:

Cystic Fibrosis
Systemic Lupus Erythematosus
IgAN

ANTH on NASDAQ

LATEST NEWS

Anthera Pharmaceuticals Announces Appointment of Dr. William Shanahan Jr. as Chief Medical Officer. Read more

Anthera Pharmaceuticals Announces Positive DSMB Review in Phase 3 SOLTUION Study of Sollpura. Read more

UPCOMING EVENTS

Anthera Clinical Program Updates Conference Call
June 29, 2016 at 8:30 AM ET

Print Friendly